Advertisement
Survey Series
Institutions
For Advertisers
|
|
||||
|
When the Line Between Science and Business Blurs
With conflicts of interest making headlines, can trust be restored?
Email: Ted Agres - tagres@the-scientist.com The Scientist 2005, 19(4):42
|
||||
|
|
||||
|
In 2004, media reports and US congressional investigations revealed that dozens of intramural scientists and officials at the National Institutes of Heath had received substantial amounts of cash and stock options by consulting with drug and biotech companies, many of which had dealings with the agency. High-profile problems with prescription drugs such as Vioxx and the controversy over antidepressant use in adolescents suggested that clinical trials conducted at the nation's most respected universities and medical centers might not tell the whole story.
|
|
|||||||||
|
|||||||||
|
